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Mitochondrion is an eukaryotic double-membrane bound
organelle that arose from a bacterial endosymbiont. Its
circular DNA is small, as many genes were transferred to
nucleus during evolution, and almost exclusively maternally
inherited. Mitochondria harbor highly regulated biogene-
sis activities (division and fusion) and motility, establish
interorganellar contacts, and perform/house multiple and
interconnected cellular functions, as diverse as ATP produc-
tion (via oxidative phosphorylation), parts of pyrimidine
and lipid biosynthetic pathways (including the fatty acid
β-oxidation pathway), reactive oxygen species production
and detoxification, and metal metabolism (synthesizing
heme and Fe–S clusters). Mitochondria also participate in
calcium homeostasis, metabolic sensing, innate immunity,
autophagy, and cell death regulation. The coordination of
these functions contributes to the cell and life balance and
mitochondrial dysfunction is consequently associated with
many human diseases.
On the one hand, discovery of the major role of
mitochondria in cell death signaling and fate has led to
important conceptual changes in oncology and has enriched
anticancer strategies. On the other hand, structurally and
functionally abnormal mitochondria have been described
in nonalcoholic fatty liver diseases, as well as many
neurodegenerative diseases including Alzheimer’s disease,
Parkinson’s disease, amyotrophic lateral sclerosis, and Hunt-
ington’s disease. Mitochondrial failure has been shown to
be central to ischemia/reperfusion damages. An energetic
imbalance involving impaired mitochondrial respiration and
substrate utilization has been demonstrated in cardiopathies
in rodents as well as in human.
Increasing evidence indicates that cytoprotection via
preservation of mitochondrial function is a promising ther-
apeutic strategy to limit the severity of the diseases and their
progression. In this special issue, we have invited reviews that
discuss the interest and the modalities of cytoprotection in
diverse conditions or experimental settings.
At the crossroad of physiology, metabolism, and toxicol-
ogy, liver mitochondria have been intensively studied. Their
particular importance in chronic liver disease is discussed by
D. Esposti and coworkers. Mitochondria also play a key role
in glucose-stimulated insulin secretion. Human pancreas
islet transplantation is a promising therapy for type I diabetes
mellitus. However, innovative methods are required for β-
cell preservation against oxidative stress, inflammation, and
cell death signaling. Y.Wang et al. present a detailed review of
the recent progress in mitochondrial cytoprotection in each
step of the islet isolation and transplantation process.
Prevention of mitochondrial membrane permeabiliza-
tion to block cell death is a powerful concept, with many
therapeutic implications in organoprotection (e.g., heart,
brain, liver, and kidneys). In a number of acute conditions
like ischemia-reperfusion, the so-called mitochondrial per-
meability transition (MPT) is an operational checkpoint to
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cell death. C. Martel et al. discuss how MPT is regulated and
can be manipulated to reduce cell death.
The clinical use of anthracyclines in anticancer therapies
is severely limited by the development of a progressive
dose-dependent cardiomyopathy that irreversibly evolves
toward congestive heart failure. D. Montaigne and coworkers
review cytoprotection strategies to reduce the cardiotoxicity
of anthracyclines.
The paper by J. Kang and S. Pervaiz addresses the central
issue of redox metabolism, and the role of mitochondria as
regulators of redox homeostasis and cell fate. They describe
how dysfunction of mitochondria and the ensuring oxidative
stress is one of the causal factors of a variety of diseases
including neurodegenerative diseases, diabetes, cardiovascu-
lar diseases, and cancer. From the current understanding of
reactive oxygen/nitrogen species generation and regulation
in the mitochondria and of their impact on cell fate, the
authors propose some clues on how redox metabolism could
be targeted for therapeutic purposes.
Oxydative stress, mitochondrial signaling, and dysfunc-
tion can also be induced through exposure to pollution
particles (for instance generated by combustion of wood or
diesel oil) and to gaseous ligands capable of binding to either
hemoglobin or mitochondrial cytochrome c oxidase (e.g.,
NO, CO, and H2S). K. Andreau et al. discuss how air pollu-
tants impact redox status, metabolic, and apoptotic functions
of mitochondria, and thereby have major consequences on
cell death and health, with societal burden. Finally, C. S. F.
Queiroga et al., focused on carbon monoxide, a toxic gas,
which can be used, however, as a therapeutic agent.
In conclusion, this special issue discusses some aspects
of cytoprotection through mitochondrial function preserva-
tion. Several of these reviews and our own past and present
research suggest that this strategy might help to delineate
eﬃcient preventive or therapeutic strategies.
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